Clinical Trial Title
The purpose of the AHEAD study is to test whether an investigational treatment can slow the earliest brain changes associated with Alzheimer's disease and can help prevent the associated memory loss.National Clinical Trial Number:
NCT04468659Contact Information
Clinical Trial Protocol Description:
The AHEAD study is to test whether an investigational treatment can slow the earliest brain changes associated with Alzheimer's disease and can help prevent the associated memory loss.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Be a healthy older adult between the ages of 55-80.
- Have an individual who knows you well willing to take part in the study with you as your study partner.
You will be excluded from the study if any of the following criteria apply to you:
- Have been diagnosed with Alzheimer's disease.
This is a partial list of inclusion and exclusion criteria.
Study Details
Clinical Trial Investigator
Neelum T. Aggarwal, MD
Contact Information
Peter Liambotis
Clinical Trial Location
Rush University Medical Center